Different analyses estimate different parameters of the effect of erythropoietin stimulating agents on survival in end stage renal disease: a comparison of payment policy analysis, instrumental variables, and multiple imputation of potential outcomes

Methods emanating from different disciplines often rely on different assumptions but can be informative about a similar causal contrast. The implications of these distinct approaches are discussed.